HBM Healthcare Correlations

HBMN Stock  CHF 189.20  2.20  1.15%   
The current 90-days correlation between HBM Healthcare Inves and BB Biotech AG is 0.26 (i.e., Modest diversification). The correlation of HBM Healthcare is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
  
The ability to find closely correlated positions to HBM Healthcare could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace HBM Healthcare when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back HBM Healthcare - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling HBM Healthcare Investments to buy it.

Moving together with HBM Stock

  0.76GALE Galenica Sante AGPairCorr
  0.83BION BB Biotech AGPairCorr
  0.68LOGN Logitech InternationalPairCorr

Moving against HBM Stock

  0.62RLF Relief TherapeuticsPairCorr
  0.54XLS Xlife Sciences AGPairCorr
  0.32BSLN Basilea PharmaceuticaPairCorr
  0.31IDIA IdorsiaPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
SLHNPGHN
PGHNBION
SLHNBION
TECNBION
TECNPGHN
SLHNTECN
  
High negative correlations   
VACNTECN
VACNBION

Risk-Adjusted Indicators

There is a big difference between HBM Stock performing well and HBM Healthcare Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze HBM Healthcare's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

Be your own money manager

Our tools can tell you how much better you can do entering a position in HBM Healthcare without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Portfolio Volatility Now

   

Portfolio Volatility

Check portfolio volatility and analyze historical return density to properly model market risk
All  Next Launch Module

HBM Healthcare Corporate Management

Elected by the shareholders, the HBM Healthcare's board of directors comprises two types of representatives: HBM Healthcare inside directors who are chosen from within the company, and outside directors, selected externally and held independent of HBM. The board's role is to monitor HBM Healthcare's management team and ensure that shareholders' interests are well served. HBM Healthcare's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, HBM Healthcare's outside directors are responsible for providing unbiased perspectives on the board's policies.
Erwin TroxlerChief OfficerProfile
Benedikt SuterS DirectorsProfile
Andreas WickiChief OfficerProfile
Thomas ThalerInvestment ProfessionalProfile
MBA MBAInvestment AdvisorProfile